Veeda Group rebrands to Veeda Lifesciences, broadening services from generics to include novel drug development.

Veeda Group has rebranded as Veeda Lifesciences, marking its shift from a generics-focused CRO to a broader drug development services provider. The company now offers services for generics and novel drugs through four units: Clinical Trials, Healthy Volunteer Services, Biopharma Services, and Preclinical & Non-Clinical Testing Services. Operating in 5 countries, Veeda aims to expand its global reach and plans to propose a public share issue in the future.

3 months ago
9 Articles